Lenalidomide-Br is a medication used in the treatment of various types of cancer, including multiple myeloma, myelodysplastic syndromes, and lymphomas. It belongs to a class of drugs called immunomodulatory drugs (IMiDs), which work by affecting the immune system and inhibiting the growth of cancer cells. Lenalidomide-Br CAS: 2093387-36-9 is a modified form of lenalidomide that has been developed to improve its potency and efficacy.
Chemical Name:
The chemical name of Lenalidomide-Br is 3-(4-bromo-1H-pyrrolo[2,3-b]pyridin-7-yloxy)-4-methoxyphenylamine.
Molecular Formula:
The molecular formula of Lenalidomide-Br is C17H15BrN2O2.
Formula Weight:
The formula weight of Lenalidomide-Br is 379.22 g/mol.
CAS No:
The CAS number of Lenalidomide-Br is 2093387-36-9.
Top Ten Keywords from Google and Synonyms:
Synonyms:
Health Benefits of this Product:
Lenalidomide-Br is primarily used in the treatment of multiple myeloma, myelodysplastic syndromes, and lymphomas. It works by affecting the immune system and inhibiting the growth of cancer cells. When taken as prescribed, it can be effective in reducing symptoms of these conditions and improving overall quality of life.
Potential Effects:
Some potential effects of Lenalidomide-Br include:
Product Mechanism:
Lenalidomide-Br works by affecting the immune system and inhibiting the growth of cancer cells. It does this by binding to specific proteins on the surface of cancer cells and promoting their destruction by the immune system. Additionally, Lenalidomide-Br can inhibit the production of cytokines, which are molecules that promote inflammation and cell growth.
In addition to its effects on the immune system and cancer cells, Lenalidomide-Br can also sensitize cancer cells to other treatments such as chemotherapy and radiation therapy.
Safety:
Like any medication, Lenalidomide-Br has potential side effects and should only be taken under the supervision of a healthcare provider. It is generally considered safe when taken as prescribed. However, some individuals may be more sensitive to the drug and experience side effects at lower doses.
Side Effects:
Some common side effects of Lenalidomide-Br include fatigue, nausea, vomiting, diarrhea, and muscle weakness. Less commonly, it can cause blood clots, heart problems, and low white blood cell counts. In rare cases, it can lead to serious side effects such as liver toxicity and severe allergic reactions.
Dosing Information:
The appropriate dosage of Lenalidomide-Br depends on the individual's age, weight, medical history, and other factors. It should only be taken as prescribed by a healthcare provider. Typically, the starting dose is 25 mg/day, which can be gradually increased over time if needed.
Conclusion:
Lenalidomide-Br is a modified form of lenalidomide that has been developed to improve its potency and efficacy. It is primarily used in the treatment of various types of cancer, particularly multiple myeloma, myelodysplastic syndromes, and lymphomas. It works by affecting the immune system and inhibiting the growth of cancer cells. While it is generally considered safe when taken as prescribed
